Skip to main content
Clinical Trials/DRKS00017569
DRKS00017569
Recruiting
Not Applicable

Multispectral Optoacoustic Tomography (MSOT) for the prediction of the response to therapy in inflammatory bowel disease (IBD). - MSOT_IBD_Therapy

niversitätsklinikum Erlangen0 sites300 target enrollmentAugust 13, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
K50.9
Sponsor
niversitätsklinikum Erlangen
Enrollment
300
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 13, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Erlangen

Eligibility Criteria

Inclusion Criteria

  • Histological verified Crohn’s disease or ulcerative colitis
  • Age \> 18 years
  • Initiation of a therapy with a biological therapeutic including or current remission
  • o Infliximab and biosimilars
  • o Adalimumab and biosimilars
  • o Golimumab (only ulcerative colitis)
  • o Vedolizumab
  • o Ustekinumab (only Crohn’s disease)
  • o Tofacintinib (only ulcerative colitis)

Exclusion Criteria

  • age \< 18 years
  • Mental retardation of the patient with restriction of general judgment and awareness
  • Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials